Showing results (181-190 of 216) with videos related to

Sort By:
Pageof 22
The New England Journal of Medicine|April 29, 2026
Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without InhibitorsMaria Elisa Mancuso, Anthony K C Chan, Chandrakala Shanmukhaiah, et al.
Blood Advances|September 14, 2022
Eltrombopag in patients with chronic immune thrombocytopenia in Asia-Pacific, the Middle East, and Turkey: final analysis of CITERaymond Siu Ming Wong, İrfan Yavaşoğlu, Mohamed A Yassin, et al.
Nature Medicine|November 20, 2025
Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trialsFeng Xue, Mankai Ju, Tienan Zhu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 3, 2020
Integrin β3 Deficiency Results in Hypertriglyceridemia via Disrupting LPL (Lipoprotein Lipase) SecretionBing Xiao, Jianhua Mao, Boyang Sun, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 27, 2022
Factor IX inhibitors in haemophilia B: A report of National Haemophilia Registry in ChinaXueqing Dou, Wenhui Zhang, Man-Chiu Poon, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 26, 2015
[Efficacy and safety of anagrelide in treatment of essential thrombocythemia: multicenter, randomized controlled clinical trial]Xiaoyan Ge, Linhua Yang, Jie Jin, et al.
Eclinicalmedicine|April 6, 2026
Daratumumab in patients with immune thrombocytopenia: a single-center, open-label, phase 2 trialYunfei Chen, Zhengjie Hua, Yanmei Xu, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 3, 2023
Women and girls with haemophilia: A retrospective cohort study in ChinaWenhui Zhang, Kuixing Li, Man-Chiu Poon, et al.
Leukemia|October 7, 2024
Childhood and adolescent essential thrombocythemia and prefibrotic primary myelofibrosis: insights into diagnosis, outcomes, and treatment from a large Chinese cohortRongfeng Fu, Huan Dong, Wenjing Gu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2024
Reduced Platelet Activation in Triple-Negative Essential Thrombocythemia Compared with JAK2V617F-Mutated Essential ThrombocythemiaHuan Dong, Jia Chen, Jing Zhang, et al.
Pageof 22